NCT03997318View on ClinicalTrials.gov

Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Stress Urinary Incontinence
Interventions
BIOLOGICAL

AMDC-USR

Autologous Muscle Derived Cells for Urinary Sphincter Repair

OTHER

Placebo

Placebo control is the vehicle solution used for the study product.

Sponsors

Lead Sponsor

Cook MyoSite
All Listed Sponsors
lead

Cook MyoSite

INDUSTRY